Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma

Treatment with programmed death-1 (PD-1) blocking antibodies results in high overall response rates in refractory and relapsed classical Hodgkin lymphoma (cHL) patients, indicating that PD-1/PD-1 ligand interactions are integral to progression of this disease. Given the genetically driven increased...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Blood Cancer J
Main Authors: Jalali, Shahrzad, Price-Troska, Tammy, Bothun, Cole, Villasboas, Jose, Kim, Hyo-Jin, Yang, Zhi-Zhang, Novak, Anne J., Dong, Haidong, Ansell, Stephen M.
Formáid: Artigo
Teanga:Inglês
Foilsithe: Nature Publishing Group UK 2019
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6381098/
https://ncbi.nlm.nih.gov/pubmed/30783096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-019-0185-9
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla